According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -1,52ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,84ย โฌ an increase over its 2021 EPS that were of -2,67ย โฌ.